Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
European Journal of Medicinal Chemistry
|
May 3, 2025
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
Giulia Cazzaniga, Davide Capelli, Roberta Montanari, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
Matteo Mori, Giovanni Stelitano, Anna Griego, et al.
European Journal of Medicinal Chemistry
|
June 24, 2026
Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights
Priam-Amedeo Houngbedji, Andrea Bachtíková, Jarmila Boháčová, et al.
European Journal of Medicinal Chemistry
|
May 20, 2008
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides
Demetrio Raffa, Benedetta Maggio, Stella Cascioferro, et al.
Chemmedchem
|
April 16, 2025
Novel Quinazolinones Active against Multidrug-Resistant Mycobacterium Tuberculosis: Synthesis, Antimicrobial Evaluation, and in Silico Exploration of Penicillin-Binding Protein 1A as a Potential Target
Marek Kerda, Daria Nawrot, Petr Slechta, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
Matteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
European Journal of Medicinal Chemistry
|
March 22, 2017
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties
Federica Porta, Giorgio Facchetti, Nicola Ferri, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
Chemmedchem
|
August 29, 2025
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives
Priam-Amedeo Houngbedji, Daria Elżbieta Nawrot, Ondřej Janďourek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
Laurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
European Journal of Medicinal Chemistry
|
May 3, 2025
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
Giulia Cazzaniga, Davide Capelli, Roberta Montanari, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
Matteo Mori, Giovanni Stelitano, Anna Griego, et al.
European Journal of Medicinal Chemistry
|
June 24, 2026
Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights
Priam-Amedeo Houngbedji, Andrea Bachtíková, Jarmila Boháčová, et al.
European Journal of Medicinal Chemistry
|
May 20, 2008
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides
Demetrio Raffa, Benedetta Maggio, Stella Cascioferro, et al.
Chemmedchem
|
April 16, 2025
Novel Quinazolinones Active against Multidrug-Resistant Mycobacterium Tuberculosis: Synthesis, Antimicrobial Evaluation, and in Silico Exploration of Penicillin-Binding Protein 1A as a Potential Target
Marek Kerda, Daria Nawrot, Petr Slechta, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
Matteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
European Journal of Medicinal Chemistry
|
March 22, 2017
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties
Federica Porta, Giorgio Facchetti, Nicola Ferri, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
Chemmedchem
|
August 29, 2025
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives
Priam-Amedeo Houngbedji, Daria Elżbieta Nawrot, Ondřej Janďourek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
Laurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Page
of 9